metastatic-recurrent HNSCC (mHNSCC) | ||
mHNSCC - L2 - all population | mHNSCC - L2 - PDL1 negative | |
Immune checkpoint association | ||
durvalumab plus tremelimumab | EAGLE ... | CONDOR ... CONDOR ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -